Triazolam tablets contain triazolam, a triazolobenzodiazepine hypnotic agent.
Triazolam is a white crystalline powder, soluble in alcohol and poorly soluble in water. It has a molecular weight of 343.21.
The chemical name for triazolam is 8-chloro-6-(o-chlorophenyl)-1-methyl-4 - -triazolo-[4,3-α][1,4]benzodiazepine.
Triazolam Tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days). Use for more than 2 to 3 weeks requires complete reevaluation of the patient (see).
Prescriptions for triazolam should be written for short-term use (7 to 10 days) and it should not be prescribed in quantities exceeding a 1-month supply.
Media Articles Related to Triazolam
Tips to Avoid Insomnia
Source: MedicineNet Sleep Specialty [2016.06.24]
Title: Tips to Avoid Insomnia
Created: 12/10/2008 12:00:00 AM
Last Editorial Review: 6/24/2016 12:00:00 AM
Menopausal Insomnia: CBT May Offer Robust, Long-term Relief
Source: Medscape NeurologyHeadlines [2016.06.22]
Cognitive behavioral therapy and sleep restriction therapy both ease insomnia symptoms and fatigue in menopausal women. However, CBT-I may be superior.
Medscape Medical News
Could less time in bed prevent chronic insomnia?
Source: Psychology / Psychiatry News From Medical News Today [2016.06.14]
New research suggests people with acute insomnia may be able to prevent it developing into chronic insomnia by spending less - not more - time in bed.
Study shows strong prevalence of insomnia symptoms among female veterans
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2016.06.10]
Over 47% of female veterans reported insomnia symptoms.A new study sheds light on the prevalence of insomnia symptoms among female veterans.
Insomnia Quiz: Test Your Sleep Hygiene IQ
Source: MedicineNet Sleep Aids And Stimulants Specialty [2016.06.07]
Title: Insomnia Quiz: Test Your Sleep Hygiene IQ
Category: MedicineNet Quiz
Created: 6/6/2016 12:00:00 AM
Last Editorial Review: 6/7/2016 2:46:56 PM
Published Studies Related to Triazolam
Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women. [2011.06]
RATIONALE: Gender plays a critical role in the effects of drugs and drug abuse liability. Biological factors, including ovarian hormones, may contribute to gender differences in drug abuse. Preclinical and some clinical research suggests that progesterone and its metabolites have activity at the GABA(A) receptor and may enhance the effect of GABAergic compounds (e.g., benzodiazepines). Because women are exposed to varying levels of progesterone from puberty until menopause, and appear more sensitive to the negative consequences of benzodiazepine use, it is important to understand the impact of progesterone on GABAergic drug effects. OBJECTIVES: The purpose of this experiment was to characterize the behavioral effects of progesterone, alone and in combination with the short-acting benzodiazepine, triazolam, to determine if progesterone potentiates the behavioral effects of triazolam... CONCLUSIONS: Progesterone potentiates the behavioral effects of benzodiazepines and may contribute to benzodiazepine use and abuse among women.
Dose effects of triazolam and scopolamine on metamemory. [2010.02]
The present study compared the acute dose effects of the benzodiazepine triazolam and the anticholinergic scopolamine on metamemory (knowledge and awareness of one's own memory) in a two-phase paradigm designed to assess effects on both monitoring and control components of metamemory in both semantic (general knowledge) and episodic memory (cued-recall) tasks...
Flumazenil reversal of sublingual triazolam: a randomized controlled clinical trial. [2009.05]
BACKGROUND: Incremental sublingual (SL) dosing of triazolam has emerged as a popular sedation technique. Nevertheless, few studies have evaluated the technique's safety or efficacy. Given its popularity, an easily administered rescue strategy is needed... CONCLUSIONS: Deep sedation from incremental SL dosing of triazolam is incompletely reversed by a single intraoral injection of flumazenil. The reversal did not persist. The authors discharged the patients from the dental clinic at 360 minutes. CLINICAL IMPLICATIONS: A single intraoral injection of flumazenil (0.2 mg) cannot immediately reverse oversedation with triazolam. A higher dose might be effective. Reversal for the purpose of discharging the patient early is neither appropriate nor safe.
Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women. [2008.04.01]
Pre-clinical studies indicate that changes in progesterone levels across menstrual cycle phases modulate the behavioral effects of sedative drugs acting at GABA(A) receptor sites. In this study, seven healthy women learned to discriminate triazolam (0.25 mg/70 kg) from placebo... These results suggest that the discriminative stimulus effects of the positive GABA(A) modulator, triazolam, are sensitive to menstrual cycle phase in healthy adult women.
Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. [2006.11]
Although preclinical studies suggest that GHB has low likelihood for abuse, case reports indicate that GHB is abused. This study evaluated the relative abuse liability of GHB in 14 volunteers with histories of drug abuse... Although the likelihood for GHB to be abused is intermediate to triazolam and pentobarbital, the possibility of accidental overdose (ie greater sedation than intended) with GHB appears to be greater.
Reports of Suspected Triazolam Side Effects
Drug Ineffective (23),
Intentional Overdose (4),
Stevens-Johnson Syndrome (4),
Maternal Exposure During Pregnancy (4),
Ventricular Tachycardia (4),
Pain (3), more >>
PATIENT REVIEWS / RATINGS / COMMENTS
Based on a total of 1 ratings/reviews, Triazolam has an overall score of 4. The effectiveness score is 8 and the side effect score is 6. The scores are on ten point scale: 10 - best, 1 - worst.
Triazolam review by 48 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Considerably Effective|
|Side effects:|| || Moderate Side Effects|
|Condition / reason:|| || Sedation Dentistry for dental implants|
|Dosage & duration:|| || 2-4 250 mg before each session taken varried - 1-3 times a month for 6 months for the period of 6 months|
|Other conditions:|| || none|
|Other drugs taken:|| || none|
|Benefits:|| || Made dental implants possible|
|Side effects:|| || The triazolam seemed to stay in my system for days. I experienced a moderate degree of memory loss. There were also a couple instances of loss of cognitive reasoning, which was most frightening.|
|Comments:|| || I had total dental implants, which involved removing my existing deteriorating teeth (full set) and then placing first, temporary titanium posts into my upper and lower jaws and then permanent posts. A series of temporary acrylic "teeth" were fashioned to fit onto the temporary and permanent posts until my gums healed. Then permanent porcelain teeth were attached to the implant posts.|
Page last updated: 2016-06-24